|
Biophan
Technologies, Inc. (OTC BB: BIPH), a leading developer
of next-generation biomedical technology, announced
today that a broad U.S. Patent has been issued to
Nanoset, LLC, Biophan's technology partner with Biophan
holding the worldwide exclusive rights for all medical
applications. The announcement was made by Michael
Weiner, Biophan's president and CEO.
The
Company noted that the nanomagnetic particle coating
technology can illuminate devices that are currently
difficult to see, either because they are invisible
to MRI or because the devices occlude the MRI image.
Combined with Biophan's safety solutions, the patented
technology is expected to help pave the way to allowing
MRI-guided surgical procedures, including minimally
invasive procedures such as those used for placing
stents, performing RF ablation, angiograms, biopsy
probes, and many other procedures.
"Biophan's
mission of creating a world-class biomedical patent
portfolio is further supported by the addition of
these patent rights to our burgeoning portfolio,"
stated Mr. Weiner. "It provides further evidence
of our clear leadership position in developing technologies
that make medical devices, such as pacemakers and
guidewires, safe for use with MRI. The potential impact
of MRI-guided surgery is far reaching and we are pleased
to be on the forefront of this revolution."
Mr.
Weiner continued, "It is clear that we are meeting
our publicly stated objective for further innovation
and market expansion. We are pleased to add these
patents to our proprietary technology base."
Mr.
Weiner went on to note, "Today, most interventional
procedures are done under CT scan or fluoroscopy,
exposing the patient and physician to ionizing radiation,
and providing a less than optimal image of tissue,
organs, and vessels. This is done in part because
of the problems that have been associated with MRI
safety and image problems associated with many medical
devices. The significance of this patent is that it
teaches how a coating on the device can change the
MRI image, reducing the artifacts, and making the
invisible devices, such as certain catheters, visible."
Mr.
Weiner concluded, "Possibly what is of greatest
commercial significance is our expanded dialog with
the MRI manufacturers and medical device manufacturers
as both groups benefit from seeing this transition
to the MRI-guided surgical center. We have found considerable
interest and support in seeing these capabilities
reach the market. We have previously indicated that
we are in discussions with biomedical device companies,
with some of these discussions in advanced stages
of negotiation. This patent is an important component
of the evolving industry interest."
U.S.
Patent No. 6,765,144 was issued to Nanoset, LLC, a
technology supplier to Biophan, with Biophan holding
the worldwide exclusive rights to all medical applications.
Biophan and Nanoset worked jointly on the innovation,
based on earlier nanotechnology patents developed
by Nanoset. A copy of the patent can be viewed on
the Company's website at http://www.biophan.com/intellectual.php.
A
graphical illustration of the potential use of this
technology can be viewed at http://www.biophan.com/mriguided1.php.
About
Nanoset, LLC
Nanoset,
LLC, based in East Rochester, NY, develops nanomagnetic
particle coatings. Nanoset's research and development
has been conducted with Alfred University, a world
leader in ceramics and thin-film coatings. Nanoset
and Biophan are jointly developing technologies for
the medical device industry.
About
Biophan Technologies
Biophan
Technologies develops and markets cutting-edge technologies
designed to make biomedical devices safe and compatible
with magnetic resonance imaging (MRI) equipment. The
Company develops enabling technologies for implanted
medical systems such as pacemakers, and interventional
surgical devices such as catheters and guidewires,
as well as stents and other implants that can be safely
and effectively imaged under MRI. The technology is
also being used to create enhanced MRI contrast agents.
Committed to growth through innovation and developmental
leadership, Biophan and its licensors have 16 issued
U.S. patents and 60 patents pending, in areas including
nanotechnology (nanomagnetic particle coatings), radio
frequency filters, polymer composites, biothermal
batteries, and photonics. Biophan's technology will
help realize its goal of one day making all biomedical
devices capable of safely and successfully working
with MRI. For more information, please visit www.biophan.com.
|
